Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Condition:   Opioid-use Disorder Interventions:   Drug: Buprenorphine/naloxone;   Drug: Placebo Sponsors:   New York State Psychiatric Institute;   National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2021 Category: Research Source Type: clinical trials

OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition:   Opioid-use Disorder Interventions:   Device: OXD01 digital therapy;   Other: Standard of Care Sponsor:   Orexo AB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials